Antibodies against phoshorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
AssigneeVasopharm Biotech GmbH
InventorsMartin Eigenthaler, Heinz Hoschuetzky, Ulrich Walter
Life of this patent
Estimating the term…
Abstract
The invention relates to antibodies against VASP (vasodilator-stimulated phosphoprotein) which only bind VASP as an antigen when VASP is present in phosphorylated form, to hybridoma cells for their preparation, and to the use of the antibodies or antibody fragments as diagnostic agents and/or therapeutic agents.
Claims3
An antigen binding protein which only binds VASP (vasodilator-stimulated phosphoprotein) as antigen when VASP is present in phosphorylated form, wherein said VASP is in the natural form or is a functionally equivalent moiety, mutant, fragment or variant thereof and wherein the antigen binding protein is monoclonal antibody 16C2 which is produced by the hybridoma cell line 16C2 deposited at the Deutsche Sammiung von Mikroorganismen und Zellkulturen under the No. DSM ACC2330.
A diagnostic kit, comprising an antigen binding protein which only recognizes VASP as antigen when VASP is present in phosphorylated form, wherein said VASP is in the natural form or is a functionally equivalent moiety, mutant, fragment or variant thereof and wherein the antigen binding protein is monoclonal antibody 16C2 which is produced by the hybridoma cell line 16C2 deposited at the Deutsche Sammiung von Mikroorganismen und Zeilkulturen under the No. DSM ACC2330.
Dependencies are inferred from the claim text.